Meeting
2019 ASCO Annual Meeting
Adaptive Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4419 in pancreatic cancer.
Authors
Jon Holmlund
Ascenta Therapeutics, Carlsbad, CA
Jon Holmlund , Melissa Brookes , Lauren Elizabeth Colbert , Shalini Moningi , Manoop S. Bhutani , Matthew H. G. Katz , Gauri Rajani Varadhachary , Peter F. Thall , Joseph M. Herman , Cullen M. Taniguchi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Clinical Trial Registration Number
NCT03340974
Citation
J Clin Oncol 37, 2019 (suppl; abstr TPS4164)
DOI
10.1200/JCO.2019.37.15_suppl.TPS4164
Abstract #
TPS4164
Poster Bd #
257b
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Adaptive dose optimization trial of stereotactic body radiation therapy (SBRT) with or without GC4419 (avasopasem manganese) in pancreatic cancer.
First Author: Elizabeth Charlotte Moser
Poster
2019 ASCO Annual Meeting
Phase II multi-institutional study of nivolumab (Nivo), cabiralizumab (Cabira), and stereotactic body radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer (LAUPC).
First Author: Deirdre Jill Cohen
Poster
2011 ASCO Annual Meeting
Fiducial-less stereotactic radiotherapy for early-stage lung cancer: Efficacy and toxicity evaluation.
First Author: J. Bibault
Poster
2024 ASCO Genitourinary Cancers Symposium
Long-term treatment outcomes from the International Multi-Institutional Stereotactic Body Radiation Therapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium.
First Author: Luca Faustino Valle